BayBio Launches New Tools For Industry-Patient Foundation Collaborations
Disease foundations are playing an increasingly important role in bringing treatments to patients and to market. We believe there is great benefit to encouraging collaboration between life science companies and these foundations.
These collaborations are playing a larger role in the strategic funding of early, innovative drug discovery programs. The foundations unique expertise in specific disease areas can be incredibly valuable in developing and disseminating new research tools, technologies and clinical protocols. Plus, their understanding of standard of care and patient needs, as well as their access to clinical thought leaders and patients, can enhance and accelerate clinical development of new treatments.
To help our member organizations, BayBio is dedicating new resources to promote and enhance industry-foundation collaborations. At baybio.org/patientcollaborations/, you’ll to find new tools to help you build your relationships.
As a starting point, BayBio surveyed and conducted in-depth interviews with industry and foundation executives to understand how these leaders are working together, and what they view as the key opportunities and challenges of industry-foundation collaborations. The result is Successful Public-Private Partnerships: A National Survey and Leadership Perspectives Guide to Effective Patient Foundation and Life Science Industry Collaborations.
Our intention is to provide practical advice to life science companies and disease foundations on how to form and manage successful collaborations. To encourage more interactions in the coming months, BayBio will conduct seminars and workshops, and issue a series of focused reports on key subjects, including partnering for funding, patient driven clinical trial design and recruitment, and regulatory and payor considerations.
If you have ideas for programs and events, please contact Scott Miller at email@example.com.